Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call. My name is Ezra, and I will be your coordinator today. (Operator Instructions) I ...

Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 fourth-quarter conference call.

Q4 2024 Management View CEO Marc Casper highlighted a strong finish to 2024, with revenue growing 5% year-over-year to $11.4 billion and adjusted EPS up 8% to $6.10. He emphasized market share gains ...

Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman, President and Chief Executive Officer; and Stephen Williamson, Senior Vice President and Chief ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.

Thermo Fisher Scientific Inc (TMO) reports robust Q4 performance with significant revenue and EPS growth, while navigating ...

Thermo Fisher Scientific (TMO) stock gains as the company beats Q4 2024 expectations and sets 2025 earnings outlook in line ...

Thermo Fisher Scientific posted higher profit and revenue in the fourth quarter, and expressed confidence for the year ahead. The Waltham, Mass., maker of microscopes and other life-sciences and ...

Reports Q4 revenue $11.40B, consensus $11.28B. “We finished 2024 with excellent financial performance, delivering strong growth on the top and ...

Core organic revenue rose 5%. "We are in a great position to deliver excellent performance in 2025," Chief Executive Marc Casper said.